Innovative Clinical Solutions, Ltd.

Innovative Clinical Solutions, Ltd. (ICSL) is a contract research organization engaged in the management of investigative clinical site. The company operates through its subsidiary, Clinical Studies, Ltd. (CSL). It offers services in three divisions, namely, clinical Trials, medical Information technologies and drug discovery. Clinical Trials division provides Phase I-IV clinical trials services. Medical Information Technologies division has developed proprietary approach which helps in communicating and implementing medical information in the neuropsychiatric field with the clinical assessment. Its Drug Discovery division helps in identification, development and planning of new potential drug candidate. ICSL owns 42% of CNS after it completed its merger with CSL. The company is headquartered in Providence, the US.

Street: 
10 Dorrance Street
City: 
Providence
Postcode: 
02903
Federal State : 
United States
Fax: 
1-401-8316758

Company Index Score

Current Index Score Historical Index Score
  • Innovative Clinical Solutions, Ltd. currently scores 50 % in the index.
  • Innovative Clinical Solutions, Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Innovative Clinical Solutions, Ltd. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets